BIOS Capital Management, LP
Follow13F filer, CIK 1813845, Fort Worth, TX
BIOS Capital Management, LP reported $34,170,550 across 6 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.
Accepted , ingested 13F-HR 0001813845-26-000009
- Period
- 2026-09-30
- Reported value
- $34.2M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group BIOS Capital Management, LP
How groups are builtLargest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LTRNreduced | -13,502 | -$13.6K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001813845-26-000009, largest first. % of portfolio is the value over $34,170,550, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| IRDOPUS GENETICS INC | 3,683,429 | $17.8M | 52.17% | 0 | Timeline | ||
| ACTUACTUATE THERAPEUTICS INC | 10,049,996 | $7.84M | 22.94% | 0 | Timeline | ||
| CGTXCOGNITION THERAPEUTICS INC | 6,000,000 | $5.76M | 16.86% | 0 | Timeline | ||
| RNTXREIN THERAPEUTICS INC | 2,982,375 | $2.4M | 7.02% | 0 | Timeline | ||
| LTRNLANTERN PHARMA INC | 235,895 | $238K | 0.7% | -13,502 | Timeline | ||
| INABIN8BIO INC | 80,957 | $108K | 0.32% | 0 | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001813845-26-000009 | base | 2026-11-13 |